Videos Library
Biopharmaceutical Acceleration Model for product development and commercialization
Related topics:
Pharmaceutical/Biotech, Medical Affairs & Stakeholder Engagement, Real-World Evidence & Late-Phase Research
Overview
- Historically, product development has largely been disengaged from commercialization
- However, in the current environment, health system stakeholders demand both clinical and real-world evidence to inform decisions regarding product use and reimbursement
- This presentation will describe and illustrate with a case study the benefits of a Biopharmaceutical Acceleration Model approach to product development and commercialization, involving comprehensive evidence development to meet clinical, regulatory, and commercial needs
Speaker
Erwin De Cock
Principal, Real-World & Late Phase
Syneos Health
Subscribe or unlock this video to download the presentation slides. If you already have an account, please log in.
REMINDER
This is the presenters’ personal opinion and does not necessarily represent true facts, the official views or policy of their organisation, nor the views of Evidence Life Science.
Sponsor
